COFOE MEDICAL (01187) · Company profile · Eqvero

COFOE MEDICAL

01187HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	3.25 bn CNY	2.84 bn CNY	2.71 bn CNY	2.87 bn CNY	2.13 bn CNY
Cost of revenue	1.44 bn CNY	1.31 bn CNY	1.53 bn CNY	1.74 bn CNY	1.23 bn CNY
Research and development expense	88.17 m CNY	97.12 m CNY	114.8 m CNY	118.96 m CNY	71.03 m CNY
Selling, general and administrative expense	1.33 bn CNY	1.09 bn CNY	851.63 m CNY	740.79 m CNY	471.17 m CNY
Operating profit after depreciation	334.51 m CNY	309.73 m CNY	210.31 m CNY	244.99 m CNY	420.89 m CNY
Operating profit before depreciation	518.48 m CNY	471.49 m CNY	346.52 m CNY	344.66 m CNY	486.16 m CNY
EBIT	334.51 m CNY	309.73 m CNY	210.31 m CNY	244.99 m CNY	420.89 m CNY
EBITDA	518.48 m CNY	471.49 m CNY	346.52 m CNY	344.66 m CNY	486.16 m CNY
Interest expense	16.07 m CNY	17.91 m CNY	13.5 m CNY	10.85 m CNY	6.81 m CNY
Profit before tax	425.84 m CNY	372 m CNY	285.71 m CNY	334.39 m CNY	508.33 m CNY
Income tax expense	55.53 m CNY	59.66 m CNY	32.84 m CNY	32.37 m CNY	78.74 m CNY
Income before extraordinary items	371.61 m CNY	311.75 m CNY	254.28 m CNY	301.68 m CNY	428.86 m CNY
Common dividends	—	366.11 m CNY	244.44 m CNY	245.77 m CNY	256.6 m CNY
Total dividends	—	366.11 m CNY	244.44 m CNY	245.77 m CNY	256.6 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.